Head-to-head · WeighScore
Carocare Wellness vs FuturHealth
The verdict
FuturHealth takes it — 65.6/100 to 58.1/100.
FuturHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Carocare Wellness | FuturHealth |
|---|---|---|
| WeighScore | 58.1/100 | 65.6/100 |
| Grade | C | C |
| Scorecard rank | #378 | #215 |
| Semaglutide | $170/mo (compounded) | $199/mo (compounded) |
| Tirzepatide | $200/mo (compounded) | Not disclosed |
| Coverage | 1 state | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #378 · C
Strengths
- Real, named local clinic in Houston with hands-on provider support, in-person visits and Google-reviewed patient experiences
- Low entry pricing — semaglutide from $170 and tirzepatide from $200 in month 1, with 3-month bundles ($500 / $600) that cut the effective monthly cost
- Packages include ongoing provider support, supplies and delivery
- Also offers IV hydration and NAD+ if you want broader wellness services in one place
Where it loses points
- Houston/Texas only — no nationwide telehealth, so it is not an option outside the local area
- Dose-escalating pricing climbs steeply (semaglutide reaches $330 by month 5; tirzepatide $425 by month 6)
- Compounding pharmacy is not named, and there is no LegitScript or published clinical-oversight detail
- Small single-location operation with no patient portal — booking and support run through Calendly and direct contact
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
Graded #215 · C
Strengths
- LegitScript Certified and HITRUST Certified
- Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
- Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
- Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths
Where it loses points
- Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
- BBB complaints describe recurring charges without medication received — confirm cancellation flow first
- Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
- Pricing not shown until after the qualification questionnaire or portal login
- Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.